About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Tg(Thy1-PFN1*C71G)67Zxu
transgene insertion 67, Zuoshang Xu
MGI:5796269
Summary 4 genotypes
Jump to Allelic Composition Genetic Background Genotype ID
cx1
Tg(Prnp-PFN1*C71G)22Zxu/0
Tg(Thy1-PFN1*C71G)67Zxu/0
involves: FVB/N MGI:5800512
cx2
Tg(Prnp-PFN1*C71G)22Zxu/0
Tg(Thy1-PFN1*C71G)67Zxu/Tg(Thy1-PFN1*C71G)67Zxu
involves: FVB/N MGI:5800513
tg3
Tg(Thy1-PFN1*C71G)67Zxu/Tg(Thy1-PFN1*C71G)67Zxu Not Specified MGI:5800511
tg4
Tg(Thy1-PFN1*C71G)67Zxu/0 Not Specified MGI:5800510


Genotype
MGI:5800512
cx1
Allelic
Composition
Tg(Prnp-PFN1*C71G)22Zxu/0
Tg(Thy1-PFN1*C71G)67Zxu/0
Genetic
Background
involves: FVB/N
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Tg(Prnp-PFN1*C71G)22Zxu mutation (1 available)
Tg(Thy1-PFN1*C71G)67Zxu mutation (1 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
behavior/neurological
• paralysis at 305 +/-34 days

mortality/aging
• due to paralysis

muscle
• muscle weakness beginning at an average age of 295 days




Genotype
MGI:5800513
cx2
Allelic
Composition
Tg(Prnp-PFN1*C71G)22Zxu/0
Tg(Thy1-PFN1*C71G)67Zxu/Tg(Thy1-PFN1*C71G)67Zxu
Genetic
Background
involves: FVB/N
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Tg(Prnp-PFN1*C71G)22Zxu mutation (1 available)
Tg(Thy1-PFN1*C71G)67Zxu mutation (1 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
behavior/neurological
• reduced grip strength beginning at 121-150 days
• impaired vertical behavior beginning at 121-150 days
• paralysis at 211 +/-25 days

cellular
• motor neurons have reduced neurofilaments, lack a well-spread filament network and exhibit a circular distribution of neurofilaments around the cell periphery

growth/size/body
• reduced body weight beginning at 121-150 days

hematopoietic system
• microgliosis is increased in ventral horn of spinal cord at the end stage of disease

immune system
• microgliosis is increased in ventral horn of spinal cord at the end stage of disease

mortality/aging
• due to paralysis

muscle
• clusters of oxidative (SDH-strong) and weak oxidative (SDH-weak) fibers as compared to interspersed distribution found in control
• 10% of mice between 100-120 days old exhibit slight weakness (foot dragging)
• 70% of mice between 121-140 days old exhibit slight weakness
• 100% of mice between 141-170 days exhibit slight weakness, progressing to weakness (leg dragging)
• beyond 170 days, all mice progress from partial paralysis to paralysis in both fore and hind limbs
• impaired rotorod performance beginning at 121-150 days

nervous system
• microgliosis is increased in ventral horn of spinal cord at the end stage of disease
• astrogliosis is increased in ventral horn of spinal cord at the end stage of disease
• motor neurons have reduced neurofilaments, lack a well-spread filament network and exhibit a circular distribution of neurofilaments around the cell periphery
• increased muscle denervation
• motor neuron number is reduced in lumbar spinal cord at the end stage of disease (170-226 days)
• motor neuron number is reduced in the ventral horn of cervical spinal cord beginning at 132-154 days of age
• protein aggregates are visible by day 127 and gradually accumulate until death
• motor neurons exhibit widespread small particulates in the cytoplasm and neuronal processe
• 1-2% of motor neurons form large aggregates
• strong ubiquitin staining is present in motor neurons and some neuropils
• p62/SQSTM1 staining is present as small particulates in cytoplasm of motor neurons
• increased cellulation (and GFAP staining) in medulla
• neuronal loss is not observed in cerebral cortex, hippocampus or cerebellum
• axon loss is progressive
• increased number of degenerating axons in the ventral root in 100-120 day old mice as compared to controls
• axon degeneration is observed in the dorsal root, but progression lags behind ventral root axons
• axon degeneration is observed in white matter of spinal cord; degeneration is mild in lateral column and more severe in ventral column
• little axon degeneration is observed in the cortical spinal track in the dorsal column

Mouse Models of Human Disease
DO ID OMIM ID(s) Ref(s)
amyotrophic lateral sclerosis type 18 DOID:0060209 OMIM:614808
J:235427




Genotype
MGI:5800511
tg3
Allelic
Composition
Tg(Thy1-PFN1*C71G)67Zxu/Tg(Thy1-PFN1*C71G)67Zxu
Genetic
Background
Not Specified
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Tg(Thy1-PFN1*C71G)67Zxu mutation (1 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
behavior/neurological
• paralysis at 321 +/-38 days

mortality/aging
• due to paralysis

muscle
• muscle weakness beginning at an average age of 150 days




Genotype
MGI:5800510
tg4
Allelic
Composition
Tg(Thy1-PFN1*C71G)67Zxu/0
Genetic
Background
Not Specified
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Tg(Thy1-PFN1*C71G)67Zxu mutation (1 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
behavior/neurological
• paralysis at 421 +/-52 days

mortality/aging
• due to paralysis

muscle
• muscle weakness beginning at an average age of 350 days





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
11/12/2024
MGI 6.24
The Jackson Laboratory